0001437749-16-037291.txt : 20160812 0001437749-16-037291.hdr.sgml : 20160812 20160812135937 ACCESSION NUMBER: 0001437749-16-037291 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 41 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160812 DATE AS OF CHANGE: 20160812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTRUSION INC CENTRAL INDEX KEY: 0000736012 STANDARD INDUSTRIAL CLASSIFICATION: COMPUTER COMMUNICATIONS EQUIPMENT [3576] IRS NUMBER: 751911917 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-20191 FILM NUMBER: 161827601 BUSINESS ADDRESS: STREET 1: 1101 ARAPAHO ROAD CITY: RICHARDSON STATE: TX ZIP: 75081 BUSINESS PHONE: 9722346400 MAIL ADDRESS: STREET 1: 1101 ARAPAHO ROAD CITY: RICHARDSON STATE: TX ZIP: 75081 FORMER COMPANY: FORMER CONFORMED NAME: INTRUSION COM INC DATE OF NAME CHANGE: 20000601 FORMER COMPANY: FORMER CONFORMED NAME: ODS NETWORKS INC DATE OF NAME CHANGE: 19970507 FORMER COMPANY: FORMER CONFORMED NAME: OPTICAL DATA SYSTEMS INC DATE OF NAME CHANGE: 19950517 10-Q 1 intz20160809_10q.htm FORM 10-Q intz20160809_10q.htm

 



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2016

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to                        

 

Commission File Number 0-20191

 

INTRUSION INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

75-1911917

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

1101 East Arapaho Road, Suite 200, Richardson, Texas 75081

(Address of principal executive offices)

(Zip Code)

 

(972) 234-6400

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

* * * * * * * * * *

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

  

           Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

 

Large accelerated filer  ☐

Accelerated filer    ☐   

 
 

Non-accelerated filer    ☐

Smaller reporting company   ☒

 
 

(Do not check if a smaller reporting company)

 

 

                                  

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No ☒

 

The number of shares outstanding of the Registrant’s Common Stock, $0.01 par value, on August 1, 2016 was 12,747,836.

 

 



 

 
1

 

  

INTRUSION INC.

 

INDEX

 

PART I – FINANCIAL INFORMATION

 3
   

Item 1. Financial Statements

 3
   

     Unaudited Condensed Consolidated Balance Sheets as of June 30, 2016 and December 31, 2015

 3
   

     Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2016 and 2015

 4
   

     Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended  June 30, 2016 and 2015

 5
   

     Notes to Unaudited Condensed Consolidated Financial Statements

 6
   

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 9
   

Item 4. Controls and Procedures

 12
   

PART II – OTHER INFORMATION

 13
   

Item 1. Legal Proceedings

 13
   

Item 1A. Risk Factors

 13
   

Item 6. Exhibits

 15
   

Signature Page

 16

 

 

 
2

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. FINANCIAL STATEMENTS

 

 

INTRUSION INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value amounts)

 

   

June 30,

2016

   

December 31,
20
15

 

ASSETS

               

Current Assets:

               

Cash and cash equivalents

  $ 566     $ 102  

Accounts receivable

    559       580  

Inventories

    53       45  

Prepaid expenses

    56       69  

Total current assets

    1,234       796  

Property and equipment, net

    367       486  

Other assets

    41       43  

TOTAL ASSETS

  $ 1,642     $ 1,325  
                 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

               
                 

Current Liabilities:

               

Accounts payable and accrued expenses

  $ 912     $ 840  

Dividends payable

    231       160  

Obligations under capital lease, current portion

    160       197  

Deferred revenue

    965       386  

Total current liabilities

    2,268       1,583  
                 

Loan payable to officer

    2,055       1,530  

Obligations under capital lease, noncurrent portion

    77       139  
                 

Commitments and contingencies

               
                 

Stockholders’ deficit:

               
Preferred stock, $0.01 par value:                

Authorized shares – 5,000

               

Series 1 shares issued and outstanding — 200 Liquidation preference of $1,088 in 2016 and $1,063 in 2015

    707       707  

Series 2 shares issued and outstanding — 460 Liquidation preference of $1,241 in 2016 and $1,212 in 2015

    724       724  

Series 3 shares issued and outstanding — 289 Liquidation preference of $681 in 2016 and $665 in 2015

    412       412  

Common stock, $0.01 par value:

               

Authorized shares — 80,000

               

Issued shares — 12,758 as of June 30, 2016 and 12,622 as of December 31, 2015 Outstanding shares — 12,748 as of June 30, 2016 and 12,612 as of December 31, 2015

    127       126  

Common stock held in treasury, at cost – 10 shares

    (362

)

    (362

)

Additional paid-in capital

    56,619       56,520  

Accumulated deficit

    (60,878

)

    (59,947

)

Accumulated other comprehensive loss

    (107

)

    (107

)

Total stockholders’ deficit

    (2,758

)

    (1,927

)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

  $ 1,642     $ 1,325  

 

 

 

 

See accompanying notes.

 

 
3

 

 

INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30, 2016

   

June 30, 2015

   

June 30, 2016

   

June 30, 2015

 

Net product revenue

  $ 1,587     $ 2,061     $ 3,098     $ 3,766  

Net customer support and maintenance revenue

          8             18  

Total revenue

    1,587       2,069       3,098       3,784  

Cost of product revenue

    528       779       1,067       1,408  

Cost of customer support and maintenance revenue

          3             6  

Total cost of revenue

    528       782       1,067       1,414  
                                 

Gross profit

    1,059       1,287       2,031       2,370  
                                 

Operating expenses:

                               

Sales and marketing

    419       444       847       942  

Research and development

    670       511       1,400       1,049  

General and administrative

    322       310       649       641  
                                 

Operating income (loss)

    (352

)

    22       (865

)

    (262

)

                                 

Interest expense, net

    (35

)

    (26

)

    (66

)

    (52

)

                                 

Net loss

  $ (387

)

  $ (4

)

  $ (931

)

  $ (314

)

                                 

Preferred stock dividends accrued

    (35

)

    (35

)

    (69

)

    (69

)

Net loss attributable to common stockholders

  $ (422

)

  $ (39

)

  $ (1,000

)

  $ (383

)

                                 
Net loss per share attributable to common stockholders:                                

Basic

  $ (0.03

)

  $ 0.00     $ (0.08

)

  $ (0.03

)

Diluted

  $ (0.03

)

  $ 0.00     $ (0.08

)

  $ (0.03

)

                                 
Weighted average common shares outstanding:                                

Basic

    12,748       12,612       12,726       12,584  

Diluted

    12,748       12,612       12,726       12,584  

 

 

See accompanying notes.

 

 
4

 

 

INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

 

 

   

Six Months Ended

 
   

June 30,

2016

   

June 30,
20
15

 

Operating Activities:

               

Net loss

  $ (931 )   $ (314

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

               

Depreciation and amortization

    146       162  

Stock-based compensation

    62       112  

Penalties and waived penalties on dividends

    8       1  

Changes in operating assets and liabilities:

               

Accounts receivable

    21       (773

)

Prepaid expenses and other assets

    15       1  

Inventories

    (8

)

     

Accounts payable and accrued expenses

    74       95  

Deferred revenue

    579       798  

Net cash (used in) provided by operating activities

    (34

)

    82  
                 

Investing Activities:

               

Purchases of property and equipment

    (27

)

    (71

)

                 

Financing Activities:

               

Proceeds from line of credit

    364        

Payments on line of credit

    (364

)

     

Proceeds from stock options exercised

    99       66  

Proceeds from loans from officer

    525        

Principal payments on capital leases

    (99

)

    (105

)

Net cash provided by (used in) financing activities

    525       (39

)

                 

Net increase (decrease) in cash and cash equivalents

    464       (28

)

Cash and cash equivalents at beginning of period

    102       1,006  

Cash and cash equivalents at end of period

  $ 566     $ 978  
                 

SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING ACTIVITIES:

               
                 

Preferred stock dividends accrued

  $ 69     $ 69  

Purchase of leased equipment under capital lease

  $     $ 216  

Conversion of preferred shares to common stock

  $     $  

 

  

See accompanying notes.

 

 
5

 

 

INTRUSION INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

 

1.

Description of Business

 

We develop, market and support a family of entity identification, high speed data mining, cybercrime and advanced persistent threat detection products. Our product families include:

 

 

TraceCop™ for identity discovery and disclosure,

 

Savant™ for network data mining and advanced persistent threat detection.

 

We market and distribute our products through a direct sales force to:

 

 

end-users,

 

value-added resellers,

 

system integrators,

 

managed service providers, and

 

distributors.

 

Our end-user customers include:

 

 

U.S. federal government entities,

 

local government entities,

 

banks,

 

airlines,

 

credit unions,

 

other financial institutions,

 

hospitals and other healthcare providers, and

 

other customers.

 

Essentially, our end-users can be defined as any end-users requiring network security solutions for protecting their mission critical data.

 

We were organized in Texas in September 1983 and reincorporated in Delaware in October 1995. Our principal executive offices are located at 1101 East Arapaho Road, Suite 200, Richardson, Texas 75081, and our telephone number is (972) 234-6400. Our website URL is www.intrusion.com. References to the “Company”, “we”, “us”, “our”, “Intrusion” or “Intrusion Inc.” refer to Intrusion Inc. and its subsidiaries. TraceCop and Savant are trademarks of Intrusion Inc.

 

2.     Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Item 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The December 31, 2015 balance sheet was derived from audited financial statements, but does not include all the disclosures required by accounting principles generally accepted in the United States. However, we believe that the disclosures are adequate to make the information presented not misleading. In our opinion, all the adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation have been included. The results of operations for the three month period ended June 30, 2016 are not necessarily indicative of the results that may be achieved for the full fiscal year or for any future period. The unaudited condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and notes thereto included in our annual report on Form 10-K for the year ended December 31, 2015, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 29, 2016.

 

The Company calculates the fair value of its assets and liabilities which qualify as financial instruments and includes this additional information in the notes to consolidated financial statements when the fair value is different from the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loans payable to officer are with a related party and as a result do not bear market rates of interest.  Management believes based on its current financial position that it could not obtain comparable amounts of third party financing, and as such cannot estimate the fair value of the loans payable to officer. None of these instruments are held for trading purposes.

 

 
6

 

  

3.     Inventories (In thousands)

 

   

June 30,
20
16

   

December 31,
20
15

 
                 

Inventories consist of:

               

Finished products

    53       45  

Net inventory

  $ 53       45  

 

4. Loan Payable to Officer

 

On February 5, 2015, the Company entered into an unsecured revolving promissory note to borrow up to $2,200,000 from G. Ward Paxton, the Company’s Chief Executive Officer. Under the terms of the note, the Company may borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $2,200,000 at any given time through March 2018.

 

On February 4, 2016, the Company renewed the CEO note described above on the same terms, with the Company being able to borrow, repay and reborrow on the note as needed up to an outstanding principal balance due of $2,200,000 at any given time through March 2018.

 

Amounts borrowed from this officer accrue interest at a floating rate per annum equal to Silicon Valley Bank’s (“SVB”) prime rate plus 1% (5% at June 30, 2016). All outstanding borrowings and accrued but unpaid interest is due on March 31, 2018. As of June 30, 2016, the borrowings outstanding totaled $2,055,000 and accrued interest totaled $125,000.

 

5. Line of Credit

 

On March 29, 2006, we entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) to establish a $1.0 million line of credit (the “2006 Credit Line”). On June 30, 2008, we entered into an Amended and Restated Loan and Security Agreement with SVB to, among other things, replace the 2006 Credit Line with a $2.5 million line of credit (the “2008 Credit Line”). On June 23, 2015, we entered into the Seventh Amendment to the Amended and Restated Loan and Security Agreement (as amended, the “Loan Agreement”) with SVB to replace our expiring line with a $0.625 million line of credit (the “Line of Credit”). Our obligations under the Loan Agreement were secured by substantially all of our assets, including all of our intellectual property. In addition, G. Ward Paxton, the Company’s Chairman, President and Chief Executive Officer, established a Guaranty Agreement with SVB securing all outstanding balances under the Line of Credit. Due to increasing fees associated with the Line of Credit, we chose not to renew the loan agreement on the termination date. We will replace the line with an increased commitment from the G. Ward Paxton promissory note, (Note 4 above) as needed.

 

6.     Accounting for Stock-Based Compensation

 

During the three month periods ended June 30, 2016 and 2015, the Company granted 24,000 and 27,000, respectively, of stock options to employees or directors. The Company recognized $20,000 and $44,000, respectively, of stock-based compensation expense for the three month periods ended June 30, 2016 and 2015. During the six month periods ended June 30, 2016 and 2015, the Company granted 24,000 and 40,000, respectively, of stock options to employees and directors. The Company recognized $62,000 and $112,000, respectively, of stock-based compensation expense for the six month periods ended June 30, 2016 and 2015.

 

During the three month periods ended June 30, 2016 and 2015, no options were exercised under the 2005 Plan, respectively. During the six month periods ended June 30, 2016 and 2015, 136,000 and 150,000 were exercised under the 2005 Plan, respectively.

 

 

 

 

Valuation Assumptions

 

The fair values of employee and director option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:

 

   

For Three Months Ended

June 30, 2016

   

For Three Months Ended

June 30, 2015

   

For Six

Months Ended

June 30, 2016

   

For Six

Months Ended
June 30, 2015

 
                                 

Weighted average grant date fair value

  $ 0.29     $ 1.93     $ 0.29     $ 2.11  

Weighted average assumptions used:

                               

Expected dividend yield

    0.0

%

    0.0

%

    0.0

%

    0.0

%

Risk-free interest rate

    1.38

%

    1.33

%

    1.38

%

    1.38

%

Expected volatility

    96.0

%

    170.0

%

    96.0

%

    176.3

%

Expected life (in years)

    5.0       5.0       5.0       5.0  

 

Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award. Options granted to non-employees are valued using the fair market value on each measurement date of the option.

 

7.     Net Loss Per Share

 

Basic net loss per share is computed by dividing net loss attributable to common stockholders for the period by the weighted average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares and dilutive common stock equivalents outstanding for the period. Our common stock equivalents include all common stock issuable upon conversion of preferred stock and the exercise of outstanding options and warrants. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the three month periods ended June 30, 2016 and 2015 are 3,531,361 and 3,805,910 as they are antidilutive. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the six month periods ended June 30, 2016 and 2015 are 3,552,147 and 3,864,056 as they are antidilutive.

 

8. Concentrations

 

Our operations are concentrated in one area—security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled 66.2% of total revenues for the second quarter of 2016 compared to 41.9% of total revenues for the second quarter of 2015. During the second quarter of 2016, approximately 54.4% of total revenues were attributable to three government customers compared to approximately 29.0% of total revenues attributable to two government customers in the second quarter of 2015. Sales to commercial customers totaled 33.8% of total revenue for the second quarter of 2016 compared to 58.1% of total revenue for the second quarter of 2015. During the second quarter of 2016, approximately 30.3% of total revenue was attributable to one commercial customer compared to approximately 56.4% to four commercial customers in the second quarter of 2015. Our similar product and service offerings are not viewed as individual segments, as our management analyzes the business as a whole and expenses are not allocated to each product offering.

 

9.     Commitments and Contingencies

 

We are subject from time to time to various legal proceedings and claims that arise during the ordinary course of our business. We do not believe that the outcome of those "routine" legal matters should have a material adverse effect on our consolidated financial position, operating results or cash flows; however, we can provide no assurances that legal claims that may arise in the future will not have such a material impact on the Company.

 

10.     Dividends Payable

 

During the quarter ended June 30, 2016, we accrued $13,000 in dividends payable to the holders of our 5% Preferred Stock, $14,000 in dividends payable to the holders of our Series 2 5% Preferred Stock and $8,000 in dividends payable to the holders of our Series 3 5% Preferred Stock. As of June 30, 2016, we have $231,000 in accrued and unpaid dividends.

 

Delaware law provides that we may only pay dividends out of our capital surplus or, if no surplus is available, out of our net profits for the fiscal year the dividend is declared and/or the preceding fiscal year. These dividends continue to accrue on all our outstanding shares of preferred stock, regardless of whether we are legally able to pay them. If we are unable to pay dividends on our preferred stock, we will be required to accrue an additional late fee penalty of 18% per annum on the unpaid dividends for the Series 2 Preferred Stock and Series 3 Preferred Stock. Our CEO, CFO and one outside board member who are holders of our Series 2 and Series 3 Preferred Stock have waived any possible late fee penalties. In addition to this late penalty, the holders of our Series 2 Preferred Stock and Series 3 Preferred Stock could elect to present us with written notice of our failure to pay dividends as scheduled, in which case we would have 45 days to cure such a breach. In the event that we failed to cure the breach, the holders of these shares of preferred stock would then have the right to require us to redeem their shares of preferred stock for a cash amount calculated in accordance with their respective certificates of designation. If we were required to redeem all shares of Series 2 Preferred Stock and Series 3 Preferred Stock as of August 1, 2016, the aggregate redemption price we would owe would be $2.2 million. 

 

 
8

 

 

Item 2.                 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward Looking Statements

 

This Quarterly Report on Form 10-Q, including, without limitation, the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such forward-looking statements are generally accompanied by words such as “estimate,” “expect,” “believe,” “should,” “would,” “could,” “anticipate,” “may” or other words that convey uncertainty of future events or outcomes. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations, which we describe in more detail elsewhere in this Quarterly Report on Form 10-Q in Part II Item 1A ”Risk Factors”, and in our 2015 Annual Report on Form 10-K in Item 1A “Risk Factors” include, but are not limited to:

 

 

insufficient cash to operate our business and inability to meet our liquidity requirements;

 

 

loss of revenues due to the failure of our newer products to achieve market acceptance;

 

 

our need to increase current revenue levels in order to achieve sustainable profitability;

 

 

concentration of our revenues from U.S. government entities or commercial customers and the possibility of loss of one of these customers and the unique risks associated with government customers;

 

 

our dependence on sales made through indirect channels;

 

 

our dependence on equity or debt financing provided primarily by our Chief Executive Officer in order to meet our cash flow requirements;

 

 

the adverse effect that payment of accrued dividends on our preferred stock would have on our cash resources and the substantial dilution upon the conversion or redemption of our preferred stock;

 

 

the consequences of our inability to pay scheduled dividends on shares of our preferred stock;

 

 

the potentially detrimental impact that the conversion of preferred stock would have on the price of our common stock;

 

 

the ability of our preferred stockholders to hinder additional financing; and

 

 

the influence that our management and larger stockholders have over actions taken by the Company.

 

If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary significantly from what we projected. These forward-looking statements and other statements made elsewhere in this report are made in reliance on the Private Securities Litigation Reform Act of 1995. Any forward-looking statement you read in this Quarterly Report on Form 10-Q or our Annual Report on Form 10-K reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The section below entitled “Factors That May Affect Future Results of Operations” sets forth and incorporates by reference certain factors that could cause actual future results of the Company to differ materially from these statements.

 

 

 

 

Results of Operations

 

The following table sets forth, for the periods indicated, certain financial data as a percentage of net revenues. The period-to-period comparison of financial results is not necessarily indicative of future results.

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30, 2016

   

June 30, 2015

   

June 30, 2016

   

June 30, 2015

 

Net product revenue

    100.0

%

    99.6

%

    100.0

%

    99.5

%

Net customer support and maintenance revenue

          0.4             0.5  

Total revenue

    100.0       100.0       100.0       100.0  

Cost of product revenue

    33.3       37.7       34.4       37.2  

Cost of customer support and maintenance revenue

          0.1             0.2  

Total cost of revenue

    33.3       37.8       34.4       37.4  

Gross profit

    66.7       62.2       65.6       62.6  

Operating expenses:

                               

Sales and marketing

    26.4       21.4       27.4       24.9  

Research and development

    42.2       24.7       45.2       27.7  

General and administrative

    20.3       15.0       20.9       16.9  
                                 

Operating income (loss)

    (22.2

)

    1.1       (27.9

)

    (6.9

)

                                 

Interest expense

    (2.2

)

    (1.3

)

    (2.1

)

    (1.4

)

Loss before income tax provision

    (24.4

)

    (0.2

)

    (30.0

)

    (8.3

)

                                 

Income tax provision

                       
                                 

Net income loss

    (24.4

)%

    (0.2

)%

    (30.0

)%

    (8.3

)%

Preferred stock dividends accrued

    (2.2

)

    (1.7

)

    (2.2

)

    (1.8

)

                                 

Net loss attributable to common stockholders

    (26.6

)%

    (1.9

)%

    (32.2

)%

    (10.1

)%

 

 

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30, 2016

   

June 30, 2015

   

June 30, 2016

   

June 30, 2015

 

Domestic revenues

    100.0

%

    100.0

%

    100.0

%

    100.0

%

Export revenues

                       
                                 

Net revenues

    100.0

%

    100.0

%

    100.0

%

    100.0

%

 

 

Net Revenues. Net revenues for the quarter and six months ended June 30, 2016 were $1.6 million and $3.1 million, respectively, compared to $2.1 million and $3.8 million for the same periods in 2015. Product revenues decreased $0.5 million for the quarter ended June 30, 2016, and decreased $0.7 million for the six months ended June 30, 2016 compared to the same periods in 2015. Decreased product revenues were primarily due to a decrease in sales of our Savant product line. TraceCop sales for the quarters ended June 30, 2016 and 2015 were $1.6 million and $1.3 million, respectively. Savant sales were $32 thousand for the quarter ended June 30, 2016 and were $0.8 million for the quarter ended June 30, 2015. Customer support and maintenance revenue decreased $8 thousand for the quarter ended June 30, 2016, compared to the same period in 2015. This decrease was due to the expiration of all existing maintenance contracts for the year ending December 31, 2015.

 

Concentration of Revenues. Revenues from sales to various U.S. government entities totaled $1.1 million, or 66.2% of revenues, for the quarter ended June 30, 2016 compared to $0.9 million, or 41.9% of revenues, for the same period in 2015. Revenues from sales to various U.S. government entities totaled $2.0 million, or 65.7% of revenues, for the six months ended June 30, 2016 compared to $2.0 million, or 52.0% of revenues, for the same period in 2015. Sales to commercial customers totaled 33.8% of total revenue for the second quarter of 2016 compared to 58.1% of total revenue for the second quarter of 2015. During the second quarter of 2016, approximately 30.3% of total revenue was attributable to one commercial customer compared to approximately 56.4% to four commercial customers in the second quarter of 2015. Although we expect our concentration of revenues to vary among customers in future periods depending upon the timing of certain sales, we anticipate that sales to government customers will continue to account for a significant portion of our revenues in future periods. Sales to the government present risks in addition to those involved in sales to commercial customers which could adversely affect our revenues, including, without limitation, potential disruption to appropriation and spending patterns and the government’s reservation of the right to cancel contracts and purchase orders for its convenience. Although we do not anticipate that any of our revenues with government customers will be renegotiated, a large number of cancelled or renegotiated government orders could have a material adverse effect on our financial results. Currently, we are not aware of any proposed cancellation or renegotiation of any of our existing arrangements with government entities and, historically, government entities have not cancelled or renegotiated orders which had a material adverse effect on our business.

 

 
10

 

 

Gross Profit. Gross profit was $1.1 million or 66.7% of net revenues for the quarter ended June 30, 2016, compared to $1.3 million or 62.2% of net revenues for the quarter ended June 30, 2015. Gross profit was $2.0 million or 65.6% of net revenues for the six months ended June 30, 2016 compared to $2.4 million or 62.6% of net revenues for the six months ended June 30, 2015. Gross profit on product revenues for the quarter and six months ended June 30, trended from 62.2% and 62.6%, respectively, in 2015 to 66.7% and 65.6%, respectively, in 2016 mainly due to a change in product mix. As noted previously, all current maintenance contracts expired at 2015 year-end. Gross profit decreases can be attributed to such variables as labor hours applied and department overhead. Gross profit as a percentage of net revenues is impacted by several factors, including shifts in product mix, changes in channels of distribution, revenue volume, pricing strategies, and fluctuations in revenues of integrated third-party products..

 

Sales and Marketing. Sales and marketing expenses remained constant at $0.4 million for the quarter ended June 30, 2016 compared to $0.4 million for the same period in 2015. Sales and marketing expenses decreased to $0.8 million for the six months ended June 30, 2016 compared to $0.9 million for the same period in 2015. Decreased sales and marketing expense was due to employee attrition. Sales and marketing expenses may vary in the future. We believe that these costs will increase through the end of 2016, with increases in revenue.

 

Research and Development. Research and development expenses increased to $0.7 million for the quarter ended June 30, 2016 compared to $0.5 million for the same period in 2015. Research and development increased to $1.4 million for the six months ended June 30, 2016 compared $1.0 million in 2015.   Research and development costs are expensed in the period incurred. Research and development expenses may vary in the future; however, we believe that these costs will remain relatively constant through the end of 2016, although expenses may be increased relative to increases in revenue.

General and Administrative. General and administrative expenses remained constant at $0.3 million for the quarters ended June 30, 2016 and 2015. General and administrative expenses remained constant at $0.6 million for the six months ended June 30, 2016 and 2015. It is expected that general and administrative expenses will remain relatively constant throughout the remainder of 2016, although expenses may be increased relative to increases in revenue.

 

Interest. Net interest expense increased to $35 thousand for the quarter ended June 30, 2016 compared to $26 thousand for the same period in 2015. Net interest expense increased to $66 thousand for the six months ended June 30, 2016 compared to $52 thousand for the same period in 2015. The increase in interest expense was primarily due to increases in the loan payable to an officer. Net interest expense may vary in the future based on our level of borrowing, which will be affected by our cash flow, operating income and capital expenditures.

 

 

Liquidity and Capital Resources

 

Our principal source of liquidity at June 30, 2016, was approximately $566 thousand of cash and cash equivalents. At June 30, 2016, we had a working capital deficiency of $1.0 million compared to a $1.4 million deficiency at June 30, 2015.

 

Net cash used in operations for the six months ended June 30, 2016, was $34 thousand due to a net loss of $931 thousand and the following use of cash: a $7 thousand increase in Inventories. This was partially offset by the following sources of cash and non-cash items: $579 thousand increase in deferred revenue, $74 thousand increase in accounts payable and accrued expenses, a $20 thousand decrease in accounts receivable, a $15 thousand decrease in prepaid expenses and other assets, $48 thousand in depreciation expense, $98 thousand in amortization expense of capital leases, $62 thousand in stock-based compensation, and $8 thousand in penalties and waived penalties on dividends. Net cash provided by operations for the six months ended June 30, 2015, was $82 thousand due to the following provisions of cash and non-cash items: $798 thousand increase in deferred revenue, $95 thousand increase in accounts payable and accrued expenses, $112 thousand in stock-based compensation, $38 thousand in depreciation expense, $124 thousand in amortization expense of capital leases, $1 thousand in penalties and waived penalties on dividends and $1 thousand increase in prepaid expenses and other assets. This was partially offset by a net loss of $314 thousand and a $773 thousand increase in accounts receivable. Future fluctuations in inventory balances, accounts receivable and accounts payable will be dependent upon several factors, including, but not limited to, quarterly sales volumes and timing of invoicing, and the accuracy of our forecasts of product demand and component requirements.

 

Net cash used in investing activities for the six months ended June 30, 2016, was $27 thousand for net purchases of property and equipment, compared to $71 thousand for net purchases of property and equipment for cash used in investing activities for the six months ended June 30, 2015.

 

Net cash provided by financing activities in 2016 was $525 thousand primarily due to proceeds from a loan by an officer of $525 thousand. Other provisions were proceeds from the line-of-credit of $364 thousand and $99 thousand from the exercise of stock options. This was directly offset by the following uses of cash: $364 thousand in payments to the line-of-credit and $99 thousand payment on principal on capital leases. Net cash used by financing activities in 2015 was $39 thousand due to $105 thousand payment on principal on capital leases. This was offset by the following provisions of cash: $66 thousand on the exercise of stock options.

 

 
11

 

  

At June 30, 2016, the Company did not have any material commitments for capital expenditures.

 

During the six months ended June 30, 2016, the Company funded its operations through the use of cash and cash equivalents, borrowing against our line of credit and advances on the loan from our Chief Executive Officer.

 

On March 29, 2006, we entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) to establish a $1.0 million line of credit (the “2006 Credit Line”). On June 30, 2008, we entered into an Amended and Restated Loan and Security Agreement with SVB to, among other things, replace the 2006 Credit Line with a $2.5 million line of credit (the “2008 Credit Line”). On June 23, 2015, we entered into the Seventh Amendment to the Amended and Restated Loan and Security Agreement (as amended, the “Loan Agreement”) with SVB to replace our expiring line with a $0.625 million line of credit (the “Line of Credit”). Our obligations under the Loan Agreement were secured by substantially all of our assets, including all of our intellectual property. In addition, G. Ward Paxton, the Company’s Chairman, President and Chief Executive Officer, established a Guaranty Agreement with SVB securing all outstanding balances under the Line of Credit. Due to increasing fees associated with the Line of Credit, we chose not to renew the loan agreement on the termination date. We will replace the line with an increased commitment from the G. Ward Paxton promissory note, (Note 4) as needed.

 

As of June 30, 2016, we had cash and cash equivalents of approximately $566,000, up from approximately $102,000 as of December 31, 2015. We generated a net loss of $387,000 for the quarter ended June 30, 2016 compared to net loss of $4,000 for the quarter ended June 30, 2015. As of June 30, 2016, in addition to cash and cash equivalents of $566,000, we had $145,000 funding available from a promissory note to borrow up to $2.2 million from G. Ward Paxton, the Company’s Chief Executive Officer. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on projections of growth in revenue and net income in the coming quarters, and the borrowings available previously mentioned, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures for the next twelve months. We expect to fund our operations through anticipated Company profits and borrowings from the Company’s CEO, and possibly additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly. Any equity or debt financings, if available at all, may be on terms which are not favorable to us and, in the case of equity financings, may result in dilution to our stockholders. If our operations do not generate positive cash flow in the upcoming year, or if we are not able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.

 

We may explore the possible acquisitions of businesses, products and technologies that are complementary to our existing business. We are continuing to identify and prioritize additional security technologies, which we may wish to develop, either internally or through the licensing, or acquisition of products from third parties. While we may engage from time to time in discussions with respect to potential acquisitions, there can be no assurances that any such acquisitions will be made or that we will be able to successfully integrate any acquired business. In order to finance such acquisitions and working capital it may be necessary for us to raise additional funds through public or private financings. Any equity or debt financings, if available at all, may be on terms, which are not favorable to us and, in the case of equity financings, may result in dilution to our stockholders.

 

 

Item 4.

CONTROLS AND PROCEDURES

 

We maintain “disclosure controls and procedures,” as defined in Rule 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable assurance of achieving the desired control objectives, and we necessarily are required to apply our judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.

 

Our management, including our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2016, and concluded that the disclosure controls and procedures were effective.

 

Our management, with the participation of our principal executive officer and principal financial officer, evaluated our “internal control over financial reporting” (as defined in Rule 13a-15(f) under the Exchange Act) as of December 31, 2015, and concluded that there have not been any changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2016, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
12

 

 

PART II – OTHER INFORMATION

 

Item 1.

LEGAL PROCEEDINGS

 

We are subject from time to time to various legal proceedings and claims that arise during the ordinary course of our business. We do not believe that the outcome of those "routine" legal matters should have a material adverse effect on our consolidated financial position, operating results or cash flows; however, we can provide no assurances that legal claims that may arise will not have such a material impact in the future.

 

 

Item 1A.          RISK FACTORS

 

Factors That May Affect Future Results of Operations

 

We are providing the following information regarding changes that have occurred to previously disclosed risk factors from our Annual Report on Form 10-K for the year ended December 31, 2015. In addition to the other information set forth below and elsewhere in this report, you should consider the factors discussed under the heading “Risk Factors” in our Form 10-K for the year ended December 31, 2015 and the previous Quarterly Reports filed on Form 10-Q. The risks described in our Quarterly Reports on Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

 

We may not have sufficient cash to operate our business and may not be able to maintain certain liquidity requirements under our existing debt instruments. Additional debt and equity offerings to fund future operations may not be available and, if available, may significantly dilute the value of our currently outstanding common stock.

 

As of June 30, 2016, we had cash and cash equivalents of approximately $566,000, up from approximately $102,000 as of December 31, 2015. We generated a net loss of $387,000 for the quarter ended June 30, 2016 compared to net loss of $4,000 for the quarter ended June 30, 2015. As of June 30, 2016, in addition to cash and cash equivalents of $566,000, we had $145,000 funding available from a promissory note to borrow up to $2.2 million from G. Ward Paxton, the Company’s Chief Executive Officer. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on projections of growth in revenue and net income in the coming quarters, and the borrowings available previously mentioned, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures for the next twelve months. We expect to fund our operations through anticipated Company profits and borrowings from the Company’s CEO, and possibly additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly. Any equity or debt financings, if available at all, may be on terms which are not favorable to us and, in the case of equity financings, may result in dilution to our stockholders. If our operations do not generate positive cash flow in the upcoming year, or if we are not able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.

 

We had a net loss of $387 thousand for the quarter ended June 30, 2016, and have an accumulated deficit of $60.9 million as of June 30, 2016. To achieve annual profitability, we must generate increased revenue levels.

 

For the quarter ended June 30, 2016, we generated a net loss of $387 thousand and had an accumulated deficit of approximately $60.9 million as of June 30, 2016, compared to a net loss of $4 thousand for the quarter ended June 30, 2015 and an accumulated deficit of approximately $59.0 million at June 30, 2015. We need to sustain greater revenue levels from the sales of our products if we are to achieve annual profitability. If we are unable to achieve these revenue levels, losses could happen for the near term and possibly longer, and we may not sustain profitability or generate positive cash flow from operations.

 

A large percentage of our revenues are received from U.S. government entities/resellers, and the loss of any one of these customers could reduce our revenues and materially harm our business and prospects.

 

A large percentage of our revenues result from sales to U.S. government entities/resellers. If we were to lose one or more of these key relationships, our revenues could decline and our business and prospects may be materially harmed. We expect that even if we are successful in developing relationships with non-governmental customers, our revenues will continue to be concentrated among government entities. For the quarter ended June 30, 2016, sales to U.S. government entities/resellers collectively accounted for 66.2% of our revenues, compared to 41.9% for the comparable period in 2015. The loss of any of these key relationships may send a negative message to other U.S. government entities or non-governmental customers concerning our product offering. We cannot assure you that U.S. government entities will be customers of ours in future periods or that we will be able to diversify our customer portfolio to adequately mitigate the risk of loss of any of these customers.

 

 
13

 

  

A large percentage of our revenues are from one product line with a limited number of customers, and the decrease of revenue from sales of this product line could materially harm our business and prospects.

 

A large percentage of our revenues result from sales of our security product line. Savant revenues were $32 thousand for the quarter ended June 30, 2016 compared to $0.8 million for the same period in 2015. TraceCop revenues were $1.6 million for the quarter ended June 30, 2016, compared to $1.3 million for the same quarter in 2015. There was one individual commercial customer in the second quarter of 2016 attributable for 30.3% of total revenue compared to four customers at 56.4% for the same period in 2015 that exceeded 10% of total revenues for that quarter. If sales of this key product line were to decrease, our revenues could decline and our business and prospects may be materially harmed.

 

We are highly dependent on sales made through indirect channels, the loss of which would materially adversely affect our operations.

 

We derived 66.2% of revenue in the second quarter of 2016 through indirect channels of mainly government resellers, compared to 77.6% of our revenues in the quarter ended June 30, 2015. We must continue to expand our sales through these indirect channels in order to increase our revenues. We cannot assure you that our products will gain market acceptance in these indirect sales channels or that sales through these indirect sales channels will increase our revenues. Further, many of our competitors are also trying to sell their products through these indirect sales channels, which could result in lower prices and reduced profit margins for sales of our products.

 

You will experience substantial dilution upon the conversion or redemption of the shares of preferred stock that we issued in our private placements or in the event we raise additional funds through the issuance of new shares of our common stock or securities convertible or exercisable into shares of common stock.

 

On August 1, 2016, we had 12,747,836 shares of common stock outstanding. Upon conversion of all outstanding shares of preferred stock, we will have 13,815,279 shares of common stock outstanding, approximately an 8.4% increase in the number of shares of our common stock outstanding.

 

In addition, management may issue additional shares of common stock or securities exercisable or convertible into shares of common stock in order to finance our continuing operations. Any future issuances of such securities would have additional dilutive effects on the existing holders of our Common Stock.

 

Further, the occurrence of certain events could entitle holders of our Series 2 Preferred Stock and Series 3 Preferred Stock to require us to redeem their shares for a certain number of shares of our common stock. Assuming (i) we have paid all liquidated damages and other amounts to the holders, (ii) paid all outstanding dividends, (iii) a volume weighted average price of $1.81, which was the ten-day volume weighted average closing price of our common stock on August 1, 2016, and (iv) our 12,747,836 shares of common stock outstanding on August 1, 2016, upon exercise of their redemption right by the holders of the Series 3 Preferred Stock and the Series 2 Preferred Stock, we would be obligated to issue approximately 12,866,000 shares of our common stock. This would represent an increase of approximately 100.9% in the number of shares of our common stock as of August 1, 2016.

 

The conversion of preferred stock we issued in the private placements may cause the price of our common stock to decline.

 

The holders of the shares of our 5% Preferred Stock may freely convert their shares of preferred stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of August 1, 2016, 800,000 shares of our 5% Preferred Stock had converted into 1,272,263 shares of common stock and 200,000 shares of our 5% preferred stock, convertible into 318,065 shares of common stock, remain outstanding.

 

The holders of the shares of Series 2 5% Preferred Stock may freely convert their shares of preferred stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of August 1, 2016, 605,200 shares of Series 2 Preferred Stock had converted into 605,200 shares of common stock and 460,000 shares of Series 2 5% preferred stock remain outstanding.

 

The holders of the shares of Series 3 5% Preferred Stock may freely convert their shares of Series 3 Preferred Stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of August 1, 2016, 275,230 shares of Series 3 Preferred Stock had converted into 275,230 shares of common stock and 289,377 shares of Series 3 5% preferred stock remain outstanding.

 

For the four weeks ended on July 29, 2016, the average daily trading volume of our common stock on the OTCQB was 3,200 shares. Consequently, if holders of preferred stock elect to convert their remaining shares and sell a material amount of their underlying shares of common stock on the open market, the increase in selling activity could cause a decline in the market price of our common stock. Furthermore, these sales, or the potential for these sales, could encourage short sales, causing additional downward pressure on the market price of our common stock.

 

 
14

 

  

You will experience substantial dilution upon the exercise of stock options currently outstanding.

 

On August 1, 2016, we had 12,747,836 shares of common stock outstanding. Upon the exercising of current options exercisable at or below the exercise price of $1.10, we will have approximately 14,905,000 shares of common stock outstanding, an 18.0% increase in the number of shares of our common stock outstanding.

 

Our management and larger stockholders exercise significant control over our company and have the ability to approve or take actions that may be adverse to your interests.

 

As of August 1, 2016, our executive officers, directors and preferred stockholders beneficially own approximately 29% of our voting power. In addition, other related parties control approximately 30% of voting power. As a result, these stockholders will be able to exercise significant control over all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, which could delay or prevent someone from acquiring or merging with us. These stockholders may use their influence to approve or take actions that may be adverse to the interests of holders of our Common Stock. Further, we contemplate the possible issuance of shares of our Common Stock or of securities exercisable or convertible into shares of our Common Stock in the future to our Chief Executive Officer and Chief Financial Officer. Any such issuance will increase the percentage of stock our Chief Executive Officer, Chief Financial Officer and our management group beneficially holds.

 

 

Item 6.

Exhibits

 

The following Exhibits are filed with this report form 10-Q:

 

31.1

 

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Exchange Act.

31.2

 

Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Exchange Act.

32.1

 

Certification Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

 

XBRL Instance Document

101.SCH

 

XBRL Taxonomy Extension Schema Document

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 
15

 

 

 S I G N A T U R E S

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

INTRUSION INC.

 
     

Date: August 11, 2016

        /s/ G. Ward Paxton

   
 

G. Ward Paxton

 
 

Chairman, President & Chief Executive Officer

 
 

(Principal Executive Officer)

 
     
     

Date: August 11, 2016

        /s/ Michael L. Paxton

   
 

Michael L. Paxton

 
 

Vice President, Chief Financial Officer,
Treasurer & Secretary

 
 

(Principal Financial & Accounting Officer)

 

 

 

16 

EX-31.1 2 ex31-1.htm EXHIBIT 31.1 ex31-1.htm

EXHIBIT 31.1

 

I, G. Ward Paxton, Chief Executive Officer of Intrusion Inc., certify that:

 

 

(1)

I have reviewed this quarterly report on Form 10-Q of Intrusion Inc.;

 

 

(2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

(3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

(4)

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

(5)

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

Date: August 11, 2016

/s/ G. Ward Paxton

 
 

G. Ward Paxton

 

Chief Executive Officer

 

 

 

EX-31.2 3 ex31-2.htm EXHIBIT 31.2 ex31-2.htm

EXHIBIT 31.2

 

I, Michael L. Paxton, Chief Financial Officer of Intrusion Inc., certify that:

 

 

(1)

I have reviewed this quarterly report on Form 10-Q of Intrusion Inc.;

 

 

(2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

(3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

(4)

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

(5)

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

Date: August 11, 2016

/s/ Michael L. Paxton

 
 

Michael L. Paxton

 

Chief Financial Officer

 

EX-32.1 4 ex32-1.htm EXHIBIT 32.1 ex32-1.htm

 

EXHIBIT 32.1

 

 

CERTIFICATION PURSUANT TO RULE 13a-14(b) OF THE EXCHANGE ACT AND 18 U.S.C. SECTION 1350, AS ENACTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Intrusion Inc. (the “Company”) on Form 10-Q, for the quarter ended June 30, 2016 (the “Report”) as filed with the Securities and Exchange Commission on the date hereof, each of the undersigned Officers of the Company does hereby certify, pursuant to 18 U.S.C. Section 1350, as enacted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

August 11, 2016

/s/ G. Ward Paxton

 
 

G. Ward Paxton

 

Chief Executive Officer

 

 

August 11, 2016

/s/ Michael L. Paxton

 
 

Michael L. Paxton

 

Chief Financial Officer

 

 

 

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Report or as a separate disclosure document.

 

 

 

 

 

 

 

 

 

EX-101.INS 5 intz-20160630.xml EXHIBIT 101.INS false --12-31 Q2 2016 2016-06-30 10-Q 0000736012 12747836 Yes Smaller Reporting Company Intrusion Inc No No intz 1 0 3 2 1 4 1 P45D 0.18 912000 840000 559000 580000 -107000 -107000 56619000 56520000 20000 44000 62000 112000 3531361 3805910 3552147 3864056 1642000 1325000 1234000 796000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2.</div><div style="display: inline; FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basis of Presentation</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Item 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The December 31, 2015 balance sheet was derived from audited financial statements, but does not include all the disclosures required by accounting principles generally accepted in the United States. However, we believe that the disclosures are adequate to make the information presented not misleading. In our opinion, all the adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation have been included. The results of operations for the three month period ended June 30, 2016 are not necessarily indicative of the results that may be achieved for the full fiscal year or for any future period. The unaudited condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and notes thereto included in our annual report on Form 10-K for the year ended December&nbsp;31, 2015, filed with the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on March 29, 2016.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company calculates the fair value of its assets and liabilities which qualify as financial instruments and includes this additional information in the notes to consolidated financial statements when the fair value is different from the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Loans payable to officer are with a related party and as a result do not bear market rates of interest. &nbsp;Management believes based on its current financial position that it could not obtain comparable amounts of third party financing, and as such cannot estimate the fair value of the loans payable to officer. None of these instruments are held for trading purposes.</div></div></div> 216000 160000 197000 77000 139000 566000 102000 1006000 978000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">9.</div><div style="display: inline; FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Commitments and Contingencies</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We are subject from time to time to various legal proceedings and claims that arise during the ordinary course of our business. We do not believe that the outcome of those &quot;routine&quot; legal matters should have a material adverse effect on our consolidated financial position, operating results or cash flows; however, we can provide no assurances that legal claims that may arise in the future will not have such a material impact on the Company.</div></div></div> 0.01 0.01 80000000 80000000 12758000 12622000 12748000 12612000 127000 126000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">8. Concentrations</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our operations are concentrated in one area&#x2014;security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled 66.2% of total revenues for the second quarter of 2016 compared to 41.9% of total revenues for the second quarter of 2015. During the second quarter of 2016, approximately 54.4% of total revenues were attributable to three government customers compared to approximately 29.0% of total revenues attributable to two government customers in the second quarter of 2015. Sales to commercial customers totaled 33.8% of total revenue for the second quarter of 2016 compared to 58.1% of total revenue for the second quarter of 2015. During the second quarter of 2016, approximately 30.3% of total revenue was attributable to one commercial customer compared to approximately 56.4% to four commercial customers in the second quarter of 2015. Our similar product and service offerings are not viewed as individual segments, as our management analyzes the business as a whole and expenses are not allocated to each product offering.</div></div></div> 0.662 0.419 0.544 0.29 0.338 0.581 0.303 0.564 528000 782000 1067000 1414000 528000 779000 1067000 1408000 3000 6000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">5. Line of Credit</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On March 29, 2006, we entered into a Loan and Security Agreement with Silicon Valley Bank (&#x201c;SVB&#x201d;) to establish a $1.0 million line of credit (the &#x201c;2006 Credit Line&#x201d;). On June 30, 2008, we entered into an Amended and Restated Loan and Security Agreement with SVB to, among other things, replace the 2006 Credit Line with a $2.5 million line of credit (the &#x201c;2008 Credit Line&#x201d;). On June 23, 2015, we entered into the Seventh Amendment to the Amended and Restated Loan and Security Agreement (as amended, the &#x201c;Loan Agreement&#x201d;) with SVB to replace our expiring line with a $0.625 million line of credit (the &#x201c;Line of Credit&#x201d;). Our obligations under the Loan Agreement were secured by substantially all of our assets, including all of our intellectual property. In addition, G. Ward Paxton, the Company&#x2019;s Chairman, President and Chief Executive Officer, established a Guaranty Agreement with SVB securing all outstanding balances under the Line of Credit. Due to increasing fees associated with the Line of Credit, we chose not to renew the loan agreement on the termination date. We will replace the line with an increased commitment from the G. Ward Paxton promissory note, (Note 4 above) as needed. </div></div></div> 0.01 965000 386000 146000 162000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">6.</div><div style="display: inline; FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accounting for Stock-Based Compensation</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the three month periods ended June 30, 2016 and 2015, the Company granted 24,000 and 27,000, respectively, of stock options to employees or directors. The Company recognized $20,000 and $44,000, respectively, of stock-based compensation expense for the three month periods ended June 30, 2016 and 2015. During the six month periods ended June 30, 2016 and 2015, the Company granted 24,000 and 40,000, respectively, of stock options to employees and directors. The Company recognized $62,000 and $112,000, respectively, of stock-based compensation expense for the six month periods ended June 30, 2016 and 2015.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the three month periods ended June 30, 2016 and 2015, no options were exercised under the 2005 Plan, respectively. During the six month periods ended June 30, 2016 and 2015, 136,000 and 150,000 were exercised under the 2005 Plan, respectively.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Valuation Assumptions</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair values of employee and director option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">For Three Months Ended</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">For Three Months Ended </div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 30, 2015</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">For Six </div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Months Ended</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">For Six </div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Months Ended<br /></div><div style="display: inline; font-weight: bold;">June 30, 2015</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average grant date fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.29</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.93</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.29</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.11</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average assumptions used:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.38</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.33</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.38</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.38</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">96.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">170.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">96.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">176.3</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (in years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.0 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.0 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award. Options granted to non-employees are valued using the fair market value on each measurement date of the option.</div></div></div> 231000 160000 69000 69000 -0.03 0 -0.08 -0.03 -0.03 0 -0.08 -0.03 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">7.</div><div style="display: inline; FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Net Loss Per Share</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic net loss per share is computed by dividing net loss attributable to common stockholders for the period by the weighted average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares and dilutive common stock equivalents outstanding for the period. Our common stock equivalents include all common stock issuable upon conversion of preferred stock and the exercise of outstanding options and warrants. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the three month periods ended June 30, 2016 and 2015 are 3,531,361 and 3,805,910 as they are antidilutive. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the six month periods ended June 30, 2016 and 2015 are 3,552,147 and 3,864,056 as they are antidilutive.</div></div></div> 322000 310000 649000 641000 1059000 1287000 2031000 2370000 74000 95000 -21000 773000 579000 798000 8000 -15000 -1000 -35000 -26000 -66000 -52000 125000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3.</div><div style="display: inline; FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Inventories (In thousands)</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 30</div><div style="display: inline; font-weight: bold;">,<br />20</div><div style="display: inline; font-weight: bold;">16</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">December 31,<br />20</div><div style="display: inline; font-weight: bold;">15</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Inventories consist of:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Finished products</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">53</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">45</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Net inventory</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">53</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">45</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 53000 45000 53000 45000 1642000 1325000 2268000 1583000 0.05 2200000 2200000 2200000 1000000 2500000 625000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">1.</div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Description of Business</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We develop, market and support a family of entity identification, high speed data mining, cybercrime and advanced persistent threat detection products. Our product families include:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">TraceCop&#x2122; for identity discovery and disclosure,</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Savant&#x2122; for network data mining and advanced persistent threat detection.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We market and distribute our products through a direct sales force to:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">end-users,</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">value-added resellers,</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">system integrators,</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">managed service providers, and</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">distributors.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our end-user customers include:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">U.S. federal government entities,</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">local government entities,</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">banks,</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">airlines,</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">credit unions,</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">other financial institutions,</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">hospitals and other healthcare providers, and</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt">&nbsp;</td> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 3pt"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">other customers.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Essentially, our end-users can be defined as any end-users requiring network security solutions for protecting their mission critical data.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We were organized in Texas in September 1983 and reincorporated in Delaware in October 1995. Our principal executive offices are located at 1101 East Arapaho Road, Suite 200, Richardson, Texas 75081, and our telephone number is (972) 234-6400. Our website URL is www.intrusion.com. References to the &#x201c;Company&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d;, &#x201c;Intrusion&#x201d; or &#x201c;Intrusion Inc.&#x201d; refer to Intrusion Inc. and its subsidiaries. TraceCop and Savant are trademarks of Intrusion Inc.</div></div></div> 464000 -28000 525000 -39000 -34000 82000 -931000 -314000 -387000 -4000 -422000 -39000 -1000000 -383000 2055000 1530000 -352000 22000 -865000 -262000 41000 43000 27000 71000 0.05 0.05 0.05 13000 14000 8000 35000 35000 69000 69000 1088 1063 1241 1212 681 665 0.01 0.01 2200000 5000000 5000000 200000 200000 460000 460000 289000 289000 200000 200000 460000 460000 289000 289000 707000 707000 724000 724000 412000 412000 56000 69000 364000 8000 1000 525000 99000 66000 367000 486000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">4. Loan Payable to Officer</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On February 5, 2015, the Company entered into an unsecured revolving promissory note to borrow up to $2,200,000 from G. Ward Paxton, the Company&#x2019;s Chief Executive Officer. Under the terms of the note, the Company may borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $2,200,000 at any given time through March 2018.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On February 4, 2016, the Company renewed the CEO note described above on the same terms, with the Company being able to borrow, repay and reborrow on the note as needed up to an outstanding principal balance due of $2,200,000 at any given time through March 2018.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Amounts borrowed from this officer accrue interest at a floating rate per annum equal to Silicon Valley Bank&#x2019;s (&#x201c;SVB&#x201d;) prime rate plus 1% (5% at June 30, 2016). All outstanding borrowings and accrued but unpaid interest is due on March 31, 2018. As of June 30, 2016, the borrowings outstanding totaled $2,055,000 and accrued interest totaled $125,000.</div></div></div> 364000 99000 105000 670000 511000 1400000 1049000 -60878000 -59947000 1587000 2061000 3098000 3766000 1587000 2069000 3098000 3784000 8000 18000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 30</div><div style="display: inline; font-weight: bold;">,<br />20</div><div style="display: inline; font-weight: bold;">16</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">December 31,<br />20</div><div style="display: inline; font-weight: bold;">15</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Inventories consist of:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Finished products</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">53</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">45</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Net inventory</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">53</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">45</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">For Three Months Ended</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">For Three Months Ended </div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 30, 2015</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">For Six </div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Months Ended</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">For Six </div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Months Ended<br /></div><div style="display: inline; font-weight: bold;">June 30, 2015</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average grant date fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.29</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.93</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.29</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.11</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average assumptions used:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.38</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.33</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.38</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.38</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">96.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">170.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">96.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">176.3</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (in years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.0 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.0 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> 419000 444000 847000 942000 62000 112000 0 0 0 0 0.96 1.7 0.96 1.763 0.0138 0.0133 0.0138 0.0138 24000 27000 24000 40000 0.29 1.93 0.29 2.11 P5Y P5Y P5Y P5Y 0 0 136000 150000 -2758000 -1927000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">10.</div><div style="display: inline; FONT-SIZE: 3pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividends Payable</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the quarter ended June 30, 2016, we accrued $13,000 in dividends payable to the holders of our 5% Preferred Stock, $14,000 in dividends payable to the holders of our Series 2 5% Preferred Stock and $8,000 in dividends payable to the holders of our Series 3 5% Preferred Stock. As of June 30, 2016, we have $231,000</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> in accrued and unpaid dividends.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 35pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Delaware law provides that we may only pay dividends out of our capital surplus or, if no surplus is available, out of our net profits for the fiscal year the dividend is declared and/or the preceding fiscal year. These dividends continue to accrue on all our outstanding shares of preferred stock, regardless of whether we are legally able to pay them. If we are unable to pay dividends on our preferred stock, we will be required to accrue an additional late fee penalty of 18% per annum on the unpaid dividends for the Series 2 Preferred Stock and Series 3 Preferred Stock. Our CEO, CFO and one outside board member who are holders of our Series 2 and Series 3 Preferred Stock have waived any possible late fee penalties. In addition to this late penalty, the holders of our Series 2 Preferred Stock and Series 3 Preferred Stock could elect to present us with written notice of our failure to pay dividends as scheduled, in which case we would have 45 days to cure such a breach. In the event that we failed to cure the breach, the holders of these shares of preferred stock would then have the right to require us to redeem their shares of preferred stock for a cash amount calculated in accordance with their respective certificates of designation. If we were required to redeem all shares of Series 2 Preferred Stock and Series 3 Preferred Stock as of August 1, 2016, the aggregate redemption price we would owe would be $2.2 million.&nbsp;</div></div></div> 10000 10000 362000 362000 12748000 12612000 12726000 12584000 12748000 12612000 12726000 12584000 iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares 0000736012 2015-01-01 2015-06-30 0000736012 2015-04-01 2015-06-30 0000736012 us-gaap:SalesRevenueSegmentMember us-gaap:CustomerConcentrationRiskMember intz:CommercialCustomersMember 2015-04-01 2015-06-30 0000736012 us-gaap:SalesRevenueSegmentMember us-gaap:CustomerConcentrationRiskMember intz:USGovernmentMember 2015-04-01 2015-06-30 0000736012 us-gaap:CustomerConcentrationRiskMember intz:CommercialCustomersMember 2015-04-01 2015-06-30 0000736012 us-gaap:CustomerConcentrationRiskMember intz:GovernmentCustomersMember 2015-04-01 2015-06-30 0000736012 2016-01-01 2016-06-30 0000736012 intz:Series1Member 2016-01-01 2016-06-30 0000736012 intz:Series2Member 2016-01-01 2016-06-30 0000736012 intz:Series2PreferredStockAndSeries3PreferredStockMember 2016-01-01 2016-06-30 0000736012 intz:Series3Member 2016-01-01 2016-06-30 0000736012 2016-04-01 2016-06-30 0000736012 us-gaap:SalesRevenueSegmentMember us-gaap:CustomerConcentrationRiskMember intz:CommercialCustomersMember 2016-04-01 2016-06-30 0000736012 us-gaap:SalesRevenueSegmentMember us-gaap:CustomerConcentrationRiskMember intz:USGovernmentMember 2016-04-01 2016-06-30 0000736012 us-gaap:CustomerConcentrationRiskMember intz:CommercialCustomersMember 2016-04-01 2016-06-30 0000736012 us-gaap:CustomerConcentrationRiskMember intz:GovernmentCustomersMember 2016-04-01 2016-06-30 0000736012 intz:CreditLine2006Member intz:SiliconValleyBankMember 2006-03-29 0000736012 intz:CreditLine2008Member intz:SiliconValleyBankMember 2008-06-30 0000736012 2014-12-31 0000736012 2015-02-05 0000736012 us-gaap:LineOfCreditMember intz:SiliconValleyBankMember 2015-06-23 0000736012 2015-06-30 0000736012 2015-12-31 0000736012 intz:Series1Member 2015-12-31 0000736012 intz:Series2Member 2015-12-31 0000736012 intz:Series3Member 2015-12-31 0000736012 2016-02-04 0000736012 2016-06-30 0000736012 intz:Series1Member 2016-06-30 0000736012 intz:Series2Member 2016-06-30 0000736012 intz:Series3Member 2016-06-30 0000736012 2016-08-01 0000736012 intz:Series2PreferredStockAndSeries3PreferredStockMember 2016-08-01 0000736012 2018-03-31 EX-101.SCH 6 intz-20160630.xsd EXHIBIT 101.SCH 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Unaudited Condensed Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Unaudited Condensed Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 005 - Disclosure - Note 1. Description of Business link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 2. Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 3. Inventories link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 4. Loan Payable to Officer link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 5. Line of Credit link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 6. Accounting for Stock-Based Compensation link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 7. Net Loss Per Share link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 8. Concentrations link:calculationLink link:definitionLink link:presentationLink 013 - Document - Note 9. Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 10. Dividends Payable link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 3. Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 6. Accounting for Stock-Based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 2. Basis of Presentation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 3 - Inventories (Details) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 4. Loan Payable to Officer (Details Textual) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 5. Line of Credit (Details Textual) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 6. Accounting for Stock-Based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 6 - Valuation Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 7. Net Loss Per Share (Details Textual) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 8. Concentrations (Details Textual) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 10. Dividends Payable (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 7 intz-20160630_cal.xml EXHIBIT 101.CAL EX-101.DEF 8 intz-20160630_def.xml EXHIBIT 101.DEF EX-101.LAB 9 intz-20160630_lab.xml EXHIBIT 101.LAB us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate Document And Entity Information Research and development Note To Financial Statement Details Textual statementnote3inventoriestables Operating expenses: statementnote6accountingforstockbasedcompensationtables statementnote3inventoriesdetails statementnote6valuationassumptionsdetails Current Assets: Notes To Financial Statements Equity Component [Domain] Notes To Financial Statements [Abstract] Equity Components [Axis] us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Amendment Flag us-gaap_TreasuryStockValue Common stock held in treasury, at cost – 10 shares Accounts payable and accrued expenses Changes in operating assets and liabilities: Document Fiscal Year Focus Document Fiscal Period Focus Accounts receivable Nature of Operations [Text Block] Class of Stock [Axis] Document Period End Date Class of Stock [Domain] Commitments and Contingencies Disclosure [Text Block] Loan payable to officer Notes Payable, Related Parties, Noncurrent Concentration Risk Benchmark [Axis] Credit Facility [Axis] Current Fiscal Year End Date Concentration Risk Benchmark [Domain] Sales and marketing us-gaap_InterestPayableCurrent Interest Payable, Current us-gaap_PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage Dividends payable Dividends Payable, Current Document Information [Line Items] Document Information [Table] Entity Current Reporting Status Purchase of leased equipment under capital lease Entity Voluntary Filers Common stock, par value (in dollars per share) Entity Filer Category Net product revenue Preferred stock dividends accrued Document Type Concentration Risk Disclosure [Text Block] Preferred stock, shares issued (in shares) us-gaap_PreferredStockRedemptionAmount Preferred Stock, Redemption Amount Common stock, shares outstanding (in shares) Expected dividend yield Preferred stock, liquidation preference (in dollars per share) Finished products Preferred stock Interest expense, net us-gaap_StockholdersEquity Total stockholders’ deficit Financing Activities: Entity Well-known Seasoned Issuer Preferred stock, par value (in dollars per share) Preferred stock, shares authorized (in shares) us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense Statement of Financial Position [Abstract] us-gaap_CostOfGoodsAndServicesSold Total cost of revenue us-gaap_OperatingIncomeLoss Operating income (loss) Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] us-gaap_GrossProfit Gross profit us-gaap_LiabilitiesCurrent Total current liabilities intz_NumberOfOutsideBoardMembersHoldingInterestInPreferredStock Number of Outside Board Members Holding Interest In Preferred Stock Represents the number of outside board members holding interest in the entity's preferred stock. Preferred stock, shares outstanding (in shares) intz_PeriodFromIssuanceOfWrittenNoticeForFailureToPayDividendWithinWhichEntityMustCureBreach Period From Issuance of Written Notice For Failure to Pay Dividend Within Which Entity Must Cure Breach Represents the period from the issuance of written notice for failure to pay dividend within which the entity must cure the breach. intz_PreferredStockUnpaidDividendsAdditionalLateFeePenaltyPercentage Preferred Stock Unpaid Dividends Additional Late Fee Penalty Percentage Represents the percentage of additional late fee penalty the entity will be required to pay on unpaid dividends for the preferred stock. Common stock held in treasury, shares (in shares) Common stock, $0.01 par value: Authorized shares — 80,000; Issued shares — 12,758 as of June 30, 2016 and 12,622 as of December 31, 2015 Outstanding shares — 12,748 as of June 30, 2016 and 12,612 as of December 31, 2015 intz_NumberOfMajorCustomers Number of Major Customers Represents the number of major customers of the entity. intz_NumberOfAreasInWhichOperationsAreConcentrated Number of Areas in Which Operations are Concentrated Represents the number of areas in which operations of the entity are concentrated. Government Customers [Member] Government customers concentration risk. Related Party Transactions Disclosure [Text Block] Commercial Customers [Member]] Commercial customers concentration risk. Proceeds from stock options exercised U.S. Government [Member] U. S. government customer concentration risk. us-gaap_IncreaseDecreaseInInventories Inventories Common stock, shares issued (in shares) Common stock, shares authorized (in shares) Accounting Policies [Abstract] us-gaap_TableTextBlock Notes Tables Sales Revenue, Segment [Member] Statement [Table] Credit Facility [Domain] Statement [Line Items] Deferred revenue us-gaap_PolicyTextBlockAbstract Accounting Policies Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Investing Activities: Operating Activities: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net cash (used in) provided by operating activities us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net cash provided by (used in) financing activities us-gaap_NetCashProvidedByUsedInContinuingOperations Net increase (decrease) in cash and cash equivalents Scenario, Unspecified [Domain] Series 2 Preferred Stock and Series 3 Preferred Stock [Member] Series 2 preferred stock and Series 3 preferred stock. Income Statement [Abstract] Scenario [Axis] Obligations under capital lease, current portion us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage Inventories consist of: us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable Penalties and waived penalties on dividends Statement of Cash Flows [Abstract] Lender Name [Axis] us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other assets Silicon Valley Bank [Member] Silicon Valley Bank Line of Credit Facility, Lender [Domain] Credit Line, 2008 [Member] 2008 Credit Line Property and equipment, net Diluted (in dollars per share) Credit Line, 2006 [Member] 2006 Credit line. Basic (in dollars per share) Basic (in shares) Number of Instruments Held For Trading Purposes Represents the number of instruments held for trading purposes. Other assets us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Inventory Disclosure [Text Block] Diluted (in shares) Schedule of Inventory, Current [Table Text Block] Debt Disclosure [Text Block] Customer [Axis] Customer [Domain] Weighted average common shares outstanding: General and administrative Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Net customer support and maintenance revenue us-gaap_RepaymentsOfLongTermCapitalLeaseObligations Principal payments on capital leases Cost of customer support and maintenance revenue Basis of Presentation and Significant Accounting Policies [Text Block] SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING ACTIVITIES: Stockholders' Equity Note Disclosure [Text Block] Obligations under capital lease, noncurrent portion us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic Net loss attributable to common stockholders Accumulated deficit Depreciation and amortization Accumulated other comprehensive loss us-gaap_LiabilitiesAndStockholdersEquity TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT us-gaap_PreferredStockDividendsIncomeStatementImpact Preferred stock dividends accrued Preferred Stock Dividends, Income Statement Impact us-gaap_SalesRevenueNet Total revenue Net loss Net loss Legal Entity [Axis] Proceeds from loans from officer us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Cost of product revenue Commitments and contingencies Inventories Net inventory Entity Registrant Name Entity Central Index Key Entity [Domain] us-gaap_Assets TOTAL ASSETS Prepaid expenses Weighted average grant date fair value (in dollars per share) Current Liabilities: Entity Common Stock, Shares Outstanding (in shares) Stock-based compensation Line of Credit [Member] us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Additional paid-in capital us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd Line of Credit Facility, Interest Rate at Period End us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchases of property and equipment Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period us-gaap_RepaymentsOfLinesOfCredit Payments on line of credit Trading Symbol us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity us-gaap_IncreaseDecreaseInDeferredRevenue Deferred revenue Risk-free interest rate Proceeds from line of credit us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Accounts payable and accrued expenses Concentration Risk Type [Domain] Concentration Risk Type [Axis] Conversion of preferred shares to common stock Value of preferred share conversion to common stock. Customer Concentration Risk [Member] us-gaap_AssetsCurrent Total current assets Expected volatility Stockholders’ deficit: Earnings Per Share [Text Block] Net loss per share attributable to common stockholders: Series 1 [Member] Series 1 preferred stock Expected life (in years) Series 2 [Member] Series 2 preferred stock Series 3 [Member] Series 3 preferred stock Weighted average assumptions used: EX-101.PRE 10 intz-20160630_pre.xml EXHIBIT 101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
Document And Entity Information - shares
6 Months Ended
Jun. 30, 2016
Aug. 01, 2016
Document Information [Line Items]    
Entity Registrant Name Intrusion Inc  
Entity Central Index Key 0000736012  
Trading Symbol intz  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well-known Seasoned Issuer No  
Entity Common Stock, Shares Outstanding (in shares)   12,747,836
Document Type 10-Q  
Document Period End Date Jun. 30, 2016  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q2  
Amendment Flag false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2016
Dec. 31, 2015
Series 1 [Member]    
Stockholders’ deficit:    
Preferred stock $ 707,000 $ 707,000
Series 2 [Member]    
Stockholders’ deficit:    
Preferred stock 724,000 724,000
Series 3 [Member]    
Stockholders’ deficit:    
Preferred stock 412,000 412,000
Cash and cash equivalents 566,000 102,000
Accounts receivable 559,000 580,000
Inventories 53,000 45,000
Prepaid expenses 56,000 69,000
Total current assets 1,234,000 796,000
Property and equipment, net 367,000 486,000
Other assets 41,000 43,000
TOTAL ASSETS 1,642,000 1,325,000
Accounts payable and accrued expenses 912,000 840,000
Dividends payable 231,000 160,000
Obligations under capital lease, current portion 160,000 197,000
Deferred revenue 965,000 386,000
Total current liabilities 2,268,000 1,583,000
Loan payable to officer 2,055,000 1,530,000
Obligations under capital lease, noncurrent portion 77,000 139,000
Commitments and contingencies
Common stock, $0.01 par value: Authorized shares — 80,000; Issued shares — 12,758 as of June 30, 2016 and 12,622 as of December 31, 2015 Outstanding shares — 12,748 as of June 30, 2016 and 12,612 as of December 31, 2015 127,000 126,000
Common stock held in treasury, at cost – 10 shares (362,000) (362,000)
Additional paid-in capital 56,619,000 56,520,000
Accumulated deficit (60,878,000) (59,947,000)
Accumulated other comprehensive loss (107,000) (107,000)
Total stockholders’ deficit (2,758,000) (1,927,000)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 1,642,000 $ 1,325,000
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
Unaudited Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
shares in Thousands
Jun. 30, 2016
Dec. 31, 2015
Series 1 [Member]    
Preferred stock, shares issued (in shares) 200 200
Preferred stock, shares outstanding (in shares) 200 200
Preferred stock, liquidation preference (in dollars per share) $ 1,088 $ 1,063
Series 2 [Member]    
Preferred stock, shares issued (in shares) 460 460
Preferred stock, shares outstanding (in shares) 460 460
Preferred stock, liquidation preference (in dollars per share) $ 1,241 $ 1,212
Series 3 [Member]    
Preferred stock, shares issued (in shares) 289 289
Preferred stock, shares outstanding (in shares) 289 289
Preferred stock, liquidation preference (in dollars per share) $ 681 $ 665
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 5,000 5,000
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 80,000 80,000
Common stock, shares issued (in shares) 12,758 12,622
Common stock, shares outstanding (in shares) 12,748 12,612
Common stock held in treasury, shares (in shares) 10 10
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Net product revenue $ 1,587 $ 2,061 $ 3,098 $ 3,766
Net customer support and maintenance revenue 8 18
Total revenue 1,587 2,069 3,098 3,784
Cost of product revenue 528 779 1,067 1,408
Cost of customer support and maintenance revenue 3 6
Total cost of revenue 528 782 1,067 1,414
Gross profit 1,059 1,287 2,031 2,370
Operating expenses:        
Sales and marketing 419 444 847 942
Research and development 670 511 1,400 1,049
General and administrative 322 310 649 641
Operating income (loss) (352) 22 (865) (262)
Interest expense, net (35) (26) (66) (52)
Net loss (387) (4) (931) (314)
Preferred stock dividends accrued (35) (35) (69) (69)
Net loss attributable to common stockholders $ (422) $ (39) $ (1,000) $ (383)
Net loss per share attributable to common stockholders:        
Basic (in dollars per share) $ (0.03) $ 0 $ (0.08) $ (0.03)
Diluted (in dollars per share) $ (0.03) $ 0 $ (0.08) $ (0.03)
Weighted average common shares outstanding:        
Basic (in shares) 12,748 12,612 12,726 12,584
Diluted (in shares) 12,748 12,612 12,726 12,584
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Operating Activities:    
Net loss $ (931) $ (314)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 146 162
Stock-based compensation 62 112
Penalties and waived penalties on dividends 8 1
Changes in operating assets and liabilities:    
Accounts receivable 21 (773)
Prepaid expenses and other assets 15 1
Inventories (8)
Accounts payable and accrued expenses 74 95
Deferred revenue 579 798
Net cash (used in) provided by operating activities (34) 82
Investing Activities:    
Purchases of property and equipment (27) (71)
Financing Activities:    
Proceeds from line of credit 364
Payments on line of credit (364)
Proceeds from stock options exercised 99 66
Proceeds from loans from officer 525
Principal payments on capital leases (99) (105)
Net cash provided by (used in) financing activities 525 (39)
Net increase (decrease) in cash and cash equivalents 464 (28)
Cash and cash equivalents at beginning of period 102 1,006
Cash and cash equivalents at end of period 566 978
SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING ACTIVITIES:    
Preferred stock dividends accrued 69 69
Purchase of leased equipment under capital lease 216
Conversion of preferred shares to common stock
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 1. Description of Business
6 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Nature of Operations [Text Block]
 
1.
Description of Business
 
We develop, market and support a family of entity identification, high speed data mining, cybercrime and advanced persistent threat detection products. Our product families include:
 
 
TraceCop™ for identity discovery and disclosure,
 
Savant™ for network data mining and advanced persistent threat detection.
 
We market and distribute our products through a direct sales force to:
 
 
end-users,
 
value-added resellers,
 
system integrators,
 
managed service providers, and
 
distributors.
 
Our end-user customers include:
 
 
U.S. federal government entities,
 
local government entities,
 
banks,
 
airlines,
 
credit unions,
 
other financial institutions,
 
hospitals and other healthcare providers, and
 
other customers.
 
Essentially, our end-users can be defined as any end-users requiring network security solutions for protecting their mission critical data.
 
We were organized in Texas in September 1983 and reincorporated in Delaware in October 1995. Our principal executive offices are located at 1101 East Arapaho Road, Suite 200, Richardson, Texas 75081, and our telephone number is (972) 234-6400. Our website URL is www.intrusion.com. References to the “Company”, “we”, “us”, “our”, “Intrusion” or “Intrusion Inc.” refer to Intrusion Inc. and its subsidiaries. TraceCop and Savant are trademarks of Intrusion Inc.
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 2. Basis of Presentation
6 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Basis of Presentation and Significant Accounting Policies [Text Block]
2.
     
Basis of Presentation
 
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Item 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The December 31, 2015 balance sheet was derived from audited financial statements, but does not include all the disclosures required by accounting principles generally accepted in the United States. However, we believe that the disclosures are adequate to make the information presented not misleading. In our opinion, all the adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation have been included. The results of operations for the three month period ended June 30, 2016 are not necessarily indicative of the results that may be achieved for the full fiscal year or for any future period. The unaudited condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and notes thereto included in our annual report on Form 10-K for the year ended December 31, 2015, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 29, 2016.
 
The Company calculates the fair value of its assets and liabilities which qualify as financial instruments and includes this additional information in the notes to consolidated financial statements when the fair value is different from the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments.
Loans payable to officer are with a related party and as a result do not bear market rates of interest.  Management believes based on its current financial position that it could not obtain comparable amounts of third party financing, and as such cannot estimate the fair value of the loans payable to officer. None of these instruments are held for trading purposes.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 3. Inventories
6 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Inventory Disclosure [Text Block]
3.
     
Inventories (In thousands)
 
 
 
June 30
,
20
16
 
 
December 31,
20
15
 
                 
Inventories consist of:
               
Finished products
    53       45  
Net inventory
  $ 53       45  
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 4. Loan Payable to Officer
6 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
4. Loan Payable to Officer
 
On February 5, 2015, the Company entered into an unsecured revolving promissory note to borrow up to $2,200,000 from G. Ward Paxton, the Company’s Chief Executive Officer. Under the terms of the note, the Company may borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $2,200,000 at any given time through March 2018.
 
On February 4, 2016, the Company renewed the CEO note described above on the same terms, with the Company being able to borrow, repay and reborrow on the note as needed up to an outstanding principal balance due of $2,200,000 at any given time through March 2018.
 
Amounts borrowed from this officer accrue interest at a floating rate per annum equal to Silicon Valley Bank’s (“SVB”) prime rate plus 1% (5% at June 30, 2016). All outstanding borrowings and accrued but unpaid interest is due on March 31, 2018. As of June 30, 2016, the borrowings outstanding totaled $2,055,000 and accrued interest totaled $125,000.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 5. Line of Credit
6 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Debt Disclosure [Text Block]
5. Line of Credit
 
On March 29, 2006, we entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) to establish a $1.0 million line of credit (the “2006 Credit Line”). On June 30, 2008, we entered into an Amended and Restated Loan and Security Agreement with SVB to, among other things, replace the 2006 Credit Line with a $2.5 million line of credit (the “2008 Credit Line”). On June 23, 2015, we entered into the Seventh Amendment to the Amended and Restated Loan and Security Agreement (as amended, the “Loan Agreement”) with SVB to replace our expiring line with a $0.625 million line of credit (the “Line of Credit”). Our obligations under the Loan Agreement were secured by substantially all of our assets, including all of our intellectual property. In addition, G. Ward Paxton, the Company’s Chairman, President and Chief Executive Officer, established a Guaranty Agreement with SVB securing all outstanding balances under the Line of Credit. Due to increasing fees associated with the Line of Credit, we chose not to renew the loan agreement on the termination date. We will replace the line with an increased commitment from the G. Ward Paxton promissory note, (Note 4 above) as needed.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 6. Accounting for Stock-Based Compensation
6 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
6.
     
Accounting for Stock-Based Compensation
 
During the three month periods ended June 30, 2016 and 2015, the Company granted 24,000 and 27,000, respectively, of stock options to employees or directors. The Company recognized $20,000 and $44,000, respectively, of stock-based compensation expense for the three month periods ended June 30, 2016 and 2015. During the six month periods ended June 30, 2016 and 2015, the Company granted 24,000 and 40,000, respectively, of stock options to employees and directors. The Company recognized $62,000 and $112,000, respectively, of stock-based compensation expense for the six month periods ended June 30, 2016 and 2015.
 
During the three month periods ended June 30, 2016 and 2015, no options were exercised under the 2005 Plan, respectively. During the six month periods ended June 30, 2016 and 2015, 136,000 and 150,000 were exercised under the 2005 Plan, respectively.
 
 
Valuation Assumptions
 
The fair values of employee and director option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:
 
 
 
For Three Months Ended
June 30, 2016
 
 
For Three Months Ended
June 30, 2015
 
 
For Six
Months Ended
June 30, 2016
 
 
For Six
Months Ended
June 30, 2015
 
                                 
Weighted average grant date fair value
  $ 0.29     $ 1.93     $ 0.29     $ 2.11  
Weighted average assumptions used:
                               
Expected dividend yield
    0.0
%
    0.0
%
    0.0
%
    0.0
%
Risk-free interest rate
    1.38
%
    1.33
%
    1.38
%
    1.38
%
Expected volatility
    96.0
%
    170.0
%
    96.0
%
    176.3
%
Expected life (in years)
    5.0       5.0       5.0       5.0  
 
Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award. Options granted to non-employees are valued using the fair market value on each measurement date of the option.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 7. Net Loss Per Share
6 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Earnings Per Share [Text Block]
7.
     
Net Loss Per Share
 
Basic net loss per share is computed by dividing net loss attributable to common stockholders for the period by the weighted average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares and dilutive common stock equivalents outstanding for the period. Our common stock equivalents include all common stock issuable upon conversion of preferred stock and the exercise of outstanding options and warrants. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the three month periods ended June 30, 2016 and 2015 are 3,531,361 and 3,805,910 as they are antidilutive. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the six month periods ended June 30, 2016 and 2015 are 3,552,147 and 3,864,056 as they are antidilutive.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 8. Concentrations
6 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Concentration Risk Disclosure [Text Block]
8. Concentrations
 
Our operations are concentrated in one area—security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled 66.2% of total revenues for the second quarter of 2016 compared to 41.9% of total revenues for the second quarter of 2015. During the second quarter of 2016, approximately 54.4% of total revenues were attributable to three government customers compared to approximately 29.0% of total revenues attributable to two government customers in the second quarter of 2015. Sales to commercial customers totaled 33.8% of total revenue for the second quarter of 2016 compared to 58.1% of total revenue for the second quarter of 2015. During the second quarter of 2016, approximately 30.3% of total revenue was attributable to one commercial customer compared to approximately 56.4% to four commercial customers in the second quarter of 2015. Our similar product and service offerings are not viewed as individual segments, as our management analyzes the business as a whole and expenses are not allocated to each product offering.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 9. Commitments and Contingencies
6 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]
9.
     
Commitments and Contingencies
 
We are subject from time to time to various legal proceedings and claims that arise during the ordinary course of our business. We do not believe that the outcome of those "routine" legal matters should have a material adverse effect on our consolidated financial position, operating results or cash flows; however, we can provide no assurances that legal claims that may arise in the future will not have such a material impact on the Company.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 10. Dividends Payable
6 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
10.
     
Dividends Payable
 
During the quarter ended June 30, 2016, we accrued $13,000 in dividends payable to the holders of our 5% Preferred Stock, $14,000 in dividends payable to the holders of our Series 2 5% Preferred Stock and $8,000 in dividends payable to the holders of our Series 3 5% Preferred Stock. As of June 30, 2016, we have $231,000
in accrued and unpaid dividends.
 
Delaware law provides that we may only pay dividends out of our capital surplus or, if no surplus is available, out of our net profits for the fiscal year the dividend is declared and/or the preceding fiscal year. These dividends continue to accrue on all our outstanding shares of preferred stock, regardless of whether we are legally able to pay them. If we are unable to pay dividends on our preferred stock, we will be required to accrue an additional late fee penalty of 18% per annum on the unpaid dividends for the Series 2 Preferred Stock and Series 3 Preferred Stock. Our CEO, CFO and one outside board member who are holders of our Series 2 and Series 3 Preferred Stock have waived any possible late fee penalties. In addition to this late penalty, the holders of our Series 2 Preferred Stock and Series 3 Preferred Stock could elect to present us with written notice of our failure to pay dividends as scheduled, in which case we would have 45 days to cure such a breach. In the event that we failed to cure the breach, the holders of these shares of preferred stock would then have the right to require us to redeem their shares of preferred stock for a cash amount calculated in accordance with their respective certificates of designation. If we were required to redeem all shares of Series 2 Preferred Stock and Series 3 Preferred Stock as of August 1, 2016, the aggregate redemption price we would owe would be $2.2 million. 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 3. Inventories (Tables)
6 Months Ended
Jun. 30, 2016
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
 
 
June 30
,
20
16
 
 
December 31,
20
15
 
                 
Inventories consist of:
               
Finished products
    53       45  
Net inventory
  $ 53       45  
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 6. Accounting for Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2016
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
 
 
For Three Months Ended
June 30, 2016
 
 
For Three Months Ended
June 30, 2015
 
 
For Six
Months Ended
June 30, 2016
 
 
For Six
Months Ended
June 30, 2015
 
                                 
Weighted average grant date fair value
  $ 0.29     $ 1.93     $ 0.29     $ 2.11  
Weighted average assumptions used:
                               
Expected dividend yield
    0.0
%
    0.0
%
    0.0
%
    0.0
%
Risk-free interest rate
    1.38
%
    1.33
%
    1.38
%
    1.38
%
Expected volatility
    96.0
%
    170.0
%
    96.0
%
    176.3
%
Expected life (in years)
    5.0       5.0       5.0       5.0  
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 2. Basis of Presentation (Details Textual)
6 Months Ended
Jun. 30, 2016
Number of Instruments Held For Trading Purposes 0
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 3 - Inventories (Details) - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Inventories consist of:    
Finished products $ 53 $ 45
Net inventory $ 53 $ 45
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 4. Loan Payable to Officer (Details Textual) - USD ($)
6 Months Ended
Jun. 30, 2016
Mar. 31, 2018
Feb. 04, 2016
Dec. 31, 2015
Feb. 05, 2015
Line of Credit Facility, Maximum Borrowing Capacity   $ 2,200,000 $ 2,200,000   $ 2,200,000
Debt Instrument, Basis Spread on Variable Rate 1.00%        
Line of Credit Facility, Interest Rate at Period End 5.00%        
Notes Payable, Related Parties, Noncurrent $ 2,055,000     $ 1,530,000  
Interest Payable, Current $ 125,000        
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 5. Line of Credit (Details Textual) - USD ($)
Mar. 31, 2018
Feb. 04, 2016
Jun. 23, 2015
Feb. 05, 2015
Jun. 30, 2008
Mar. 29, 2006
Credit Line, 2006 [Member] | Silicon Valley Bank [Member]            
Line of Credit Facility, Maximum Borrowing Capacity           $ 1,000,000
Credit Line, 2008 [Member] | Silicon Valley Bank [Member]            
Line of Credit Facility, Maximum Borrowing Capacity         $ 2,500,000  
Line of Credit [Member] | Silicon Valley Bank [Member]            
Line of Credit Facility, Maximum Borrowing Capacity     $ 625,000      
Line of Credit Facility, Maximum Borrowing Capacity $ 2,200,000 $ 2,200,000   $ 2,200,000    
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 6. Accounting for Stock-Based Compensation (Details Textual) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 24,000 27,000 24,000 40,000
Allocated Share-based Compensation Expense $ 20,000 $ 44,000 $ 62,000 $ 112,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 0 0 136,000 150,000
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 6 - Valuation Assumptions (Details) - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Weighted average grant date fair value (in dollars per share) $ 0.29 $ 1.93 $ 0.29 $ 2.11
Weighted average assumptions used:        
Expected dividend yield 0.00% 0.00% 0.00% 0.00%
Risk-free interest rate 1.38% 1.33% 1.38% 1.38%
Expected volatility 96.00% 170.00% 96.00% 176.30%
Expected life (in years) 5 years 5 years 5 years 5 years
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 7. Net Loss Per Share (Details Textual) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3,531,361 3,805,910 3,552,147 3,864,056
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 8. Concentrations (Details Textual)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Customer Concentration Risk [Member] | U.S. Government [Member] | Sales Revenue, Segment [Member]      
Concentration Risk, Percentage 66.20% 41.90%  
Customer Concentration Risk [Member] | Government Customers [Member]      
Concentration Risk, Percentage 54.40% 29.00%  
Number of Major Customers 3 2  
Customer Concentration Risk [Member] | Commercial Customers [Member]] | Sales Revenue, Segment [Member]      
Concentration Risk, Percentage 33.80% 58.10%  
Customer Concentration Risk [Member] | Commercial Customers [Member]]      
Concentration Risk, Percentage 30.30% 56.40%  
Number of Major Customers 1 4  
Number of Areas in Which Operations are Concentrated     1
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 10. Dividends Payable (Details Textual)
3 Months Ended 6 Months Ended
Jun. 30, 2016
USD ($)
Jun. 30, 2015
USD ($)
Jun. 30, 2016
USD ($)
Jun. 30, 2015
USD ($)
Aug. 01, 2016
USD ($)
Dec. 31, 2015
USD ($)
Series 1 [Member]            
Preferred Stock Dividends, Income Statement Impact     $ 13,000      
Preferred Stock, Dividend Rate, Percentage     5.00%      
Series 2 [Member]            
Preferred Stock Dividends, Income Statement Impact     $ 14,000      
Preferred Stock, Dividend Rate, Percentage     5.00%      
Series 3 [Member]            
Preferred Stock Dividends, Income Statement Impact     $ 8,000      
Preferred Stock, Dividend Rate, Percentage     5.00%      
Series 2 Preferred Stock and Series 3 Preferred Stock [Member]            
Preferred Stock Unpaid Dividends Additional Late Fee Penalty Percentage     18.00%      
Number of Outside Board Members Holding Interest In Preferred Stock     1      
Period From Issuance of Written Notice For Failure to Pay Dividend Within Which Entity Must Cure Breach     45 days      
Preferred Stock, Redemption Amount         $ 2,200,000  
Preferred Stock Dividends, Income Statement Impact $ 35,000 $ 35,000 $ 69,000 $ 69,000    
Dividends Payable, Current $ 231,000   $ 231,000     $ 160,000
EXCEL 37 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 38 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 39 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 41 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 34 122 1 false 13 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.intrusion.com/20160630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Unaudited Condensed Consolidated Balance Sheets Sheet http://www.intrusion.com/20160630/role/statement-unaudited-condensed-consolidated-balance-sheets Unaudited Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.intrusion.com/20160630/role/statement-unaudited-condensed-consolidated-balance-sheets-parentheticals Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Unaudited Condensed Consolidated Statements of Operations Sheet http://www.intrusion.com/20160630/role/statement-unaudited-condensed-consolidated-statements-of-operations Unaudited Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows Sheet http://www.intrusion.com/20160630/role/statement-unaudited-condensed-consolidated-statements-of-cash-flows Unaudited Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 005 - Disclosure - Note 1. Description of Business Sheet http://www.intrusion.com/20160630/role/statement-note-1-description-of-business- Note 1. Description of Business Notes 6 false false R7.htm 006 - Disclosure - Note 2. Basis of Presentation Sheet http://www.intrusion.com/20160630/role/statement-note-2-basis-of-presentation- Note 2. Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 3. Inventories Sheet http://www.intrusion.com/20160630/role/statement-note-3-inventories Note 3. Inventories Notes 8 false false R9.htm 008 - Disclosure - Note 4. Loan Payable to Officer Sheet http://www.intrusion.com/20160630/role/statement-note-4-loan-payable-to-officer- Note 4. Loan Payable to Officer Notes 9 false false R10.htm 009 - Disclosure - Note 5. Line of Credit Sheet http://www.intrusion.com/20160630/role/statement-note-5-line-of-credit Note 5. Line of Credit Notes 10 false false R11.htm 010 - Disclosure - Note 6. Accounting for Stock-Based Compensation Sheet http://www.intrusion.com/20160630/role/statement-note-6-accounting-for-stockbased-compensation Note 6. Accounting for Stock-Based Compensation Notes 11 false false R12.htm 011 - Disclosure - Note 7. Net Loss Per Share Sheet http://www.intrusion.com/20160630/role/statement-note-7-net-loss-per-share Note 7. Net Loss Per Share Notes 12 false false R13.htm 012 - Disclosure - Note 8. Concentrations Sheet http://www.intrusion.com/20160630/role/statement-note-8-concentrations Note 8. Concentrations Notes 13 false false R14.htm 013 - Document - Note 9. Commitments and Contingencies Sheet http://www.intrusion.com/20160630/role/statement-note-9-commitments-and-contingencies Note 9. Commitments and Contingencies Uncategorized 14 false false R15.htm 014 - Disclosure - Note 10. Dividends Payable Sheet http://www.intrusion.com/20160630/role/statement-note-10-dividends-payable Note 10. Dividends Payable Uncategorized 15 false false R16.htm 015 - Disclosure - Note 3. Inventories (Tables) Sheet http://www.intrusion.com/20160630/role/statement-note-3-inventories-tables Note 3. Inventories (Tables) Uncategorized 16 false false R17.htm 016 - Disclosure - Note 6. Accounting for Stock-Based Compensation (Tables) Sheet http://www.intrusion.com/20160630/role/statement-note-6-accounting-for-stockbased-compensation-tables Note 6. Accounting for Stock-Based Compensation (Tables) Uncategorized 17 false false R18.htm 017 - Disclosure - Note 2. Basis of Presentation (Details Textual) Sheet http://www.intrusion.com/20160630/role/statement-note-2-basis-of-presentation-details-textual Note 2. Basis of Presentation (Details Textual) Uncategorized 18 false false R19.htm 018 - Disclosure - Note 3 - Inventories (Details) Sheet http://www.intrusion.com/20160630/role/statement-note-3-inventories-details Note 3 - Inventories (Details) Uncategorized 19 false false R20.htm 019 - Disclosure - Note 4. Loan Payable to Officer (Details Textual) Sheet http://www.intrusion.com/20160630/role/statement-note-4-loan-payable-to-officer-details-textual Note 4. Loan Payable to Officer (Details Textual) Uncategorized 20 false false R21.htm 020 - Disclosure - Note 5. Line of Credit (Details Textual) Sheet http://www.intrusion.com/20160630/role/statement-note-5-line-of-credit-details-textual Note 5. Line of Credit (Details Textual) Uncategorized 21 false false R22.htm 021 - Disclosure - Note 6. Accounting for Stock-Based Compensation (Details Textual) Sheet http://www.intrusion.com/20160630/role/statement-note-6-accounting-for-stockbased-compensation-details-textual Note 6. Accounting for Stock-Based Compensation (Details Textual) Uncategorized 22 false false R23.htm 022 - Disclosure - Note 6 - Valuation Assumptions (Details) Sheet http://www.intrusion.com/20160630/role/statement-note-6-valuation-assumptions-details Note 6 - Valuation Assumptions (Details) Uncategorized 23 false false R24.htm 023 - Disclosure - Note 7. Net Loss Per Share (Details Textual) Sheet http://www.intrusion.com/20160630/role/statement-note-7-net-loss-per-share-details-textual Note 7. Net Loss Per Share (Details Textual) Uncategorized 24 false false R25.htm 024 - Disclosure - Note 8. Concentrations (Details Textual) Sheet http://www.intrusion.com/20160630/role/statement-note-8-concentrations-details-textual Note 8. Concentrations (Details Textual) Uncategorized 25 false false R26.htm 025 - Disclosure - Note 10. Dividends Payable (Details Textual) Sheet http://www.intrusion.com/20160630/role/statement-note-10-dividends-payable-details-textual Note 10. Dividends Payable (Details Textual) Uncategorized 26 false false All Reports Book All Reports intz-20160630.xml intz-20160630.xsd intz-20160630_cal.xml intz-20160630_def.xml intz-20160630_lab.xml intz-20160630_pre.xml true true ZIP 43 0001437749-16-037291-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-16-037291-xbrl.zip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end